In order to evaluate whether SPHK1 expression was related to the therapeutic outcome in advanced melanoma patients receiving anti-PD-1 therapy (Table 1), we analyzed SPHK1 messenger RNA (mRNA) expression in tumor biopsies by in situ hybridization using the RNAscope technology. Here, PDCD1 is linked to neoplasm.